The weekly litigation news digest is live. Subscribe now

IP Verse

Method Of Identifying Treatment Responsive Non-Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (Alk) As A Marker - EP2898329

The patent EP2898329 was granted to Ventana Medical Systems on May 17, 2017. The application was filed on Mar 14, 2013 under application number EP13712120A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2898329

VENTANA MEDICAL SYSTEMS
Application Number
EP13712120A
Filing Date
Mar 14, 2013
Status
Opposition Rejected
Oct 11, 2019
Publication Date
May 17, 2017
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HOFFMANN EITLEFeb 19, 2018- -

Patent Citations (14) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0120694
DESCRIPTIONEP0125023
DESCRIPTIONEP0256654
DESCRIPTIONUS2012171668
DESCRIPTIONUS4444487
DESCRIPTIONUS4745055
DESCRIPTIONUS7230098
DESCRIPTIONUS7825137
DESCRIPTIONUS7858643
DESCRIPTIONUS8217057
DESCRIPTIONWO8803565
INTERNATIONAL-SEARCH-REPORTWO2012070730
OPPOSITIONWO2012070730
OTHERWO2012070730

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents